Noveome Biotherapeutics Announces Positive Data Safety Monitoring Board Recommendation in ongoing NEC Clinical Trial

Drug Safety Monitoring Board (DSMB) gives Noveome Biotherapeutics a recommendation to continue the Necrotizing ...
The New England Journal of Medicine

Necrotizing Enterocolitis

The financial cost of necrotizing enterocolitis is substantial; the total annual estimated cost of caring for affected infants in the United States is between $500 million and $1 billion. In one study ...
Medscape

Novel Blood Marker Can Differentiate Bacterial Infection From Severe Colitis

The monocyte distribution width derived from routine blood testing can distinguish bacterial enterocolitis from acute severe ...
Clinical Advisor

Mixed FPIES and IgE-Mediated Allergic Reactions Require Personalized Management

New data from NAPNAP 2026 emphasizes the need for dual-mechanism reaction protocols to manage atypical food protein-induced ...
ascopubs.org

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: The 20030125 Study Group Trial Cytotoxic T-lymphocyte–associated ...
Healthline

Necrotizing Enterocolitis

Necrotizing enterocolitis (NEC) is a disease that develops when the tissue in the inner lining of the small or large intestine becomes damaged and begins to die. This causes the intestine to become ...